Trials / Completed
CompletedNCT01202253
Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom
A Study To Describe The Early Clinical Experience With Anidulafungin In Patients With Liver Disease At King's College Hospital NHS Trust, London
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to describe the real world effectiveness of anidulafungin in clinical practice in a large Liver Unit in the United Kingdom.
Detailed description
All subjects that have been treated with Anidulafungin according to its licence during the period of July 2009 and September 2010 will be included.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | anidulafungin | A single 200 mg loading dose should be administered on Day 1, followed by 100 mg daily thereafter. |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2011-05-01
- Completion
- 2011-05-01
- First posted
- 2010-09-15
- Last updated
- 2014-04-16
- Results posted
- 2012-10-11
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01202253. Inclusion in this directory is not an endorsement.